Send us Feedback

Cannasat Therapeutics (CTH)
Analysis
SUMMARY
BULLS
BEARS
Data
DATA CENTRAL
STOCK CHART
Financials
BALANCE
INCOME
CASH FLOW
QUOTE AND NEWS
Cannasat changes name to Cynapsus Therapeutics
Marketwire  Apr 15  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 04/15/10 -- Cannasat Therapeutics Inc. (TSX-V: CTH) ("Cannasat") today announced that it received shareholder approval to change its corporate name to Cynapsus Therapeutics Inc. ("Cynapsus"). The approval was
Cannasat Therapeutics Reports Results for the Year Ended December 31, 2009
Marketwire  Mar 5  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 03/05/10 -- Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a specialty clinical development pharmaceutical company targeting CNS diseases, today announced its results for the year ended December 31, 2009. Unless
IntelGenx and Cannasat Announce Letter of Intent for Relivar License
Marketwire  Mar 4  Comment 
SAINT LAURENT, QC and TORONTO -- (Marketwire) -- 03/04/10 -- EMBARGOED UNTIL: 6:00am EST, Thursday, March 4, 2010 JOINT PRESS RELEASE IntelGenx and Cannasat Announce Letter of Intent for Relivar License March 4, 2010 IntelGenx Corp. (IGX) (US: IGXT)
Cannasat Announces Signing of Letter of Intent for In-Licensing of Parkinson's Disease Technology
Marketwire  Feb 4  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 02/04/10 -- Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a specialty clinical development pharmaceutical company targeting CNS illness, announced today that it has entered into a Letter of Intent ("LOI") with
Cannasat Therapeutics Reports Results for the Six Months Ended June 30, 2009
Marketwire  Aug 31  Comment 
TORONTO ONTARIO, U.S.A. -- (Marketwire) -- 08/31/09 -- PRESS RELEASE Cannasat Therapeutics Reports Results for the Six Months Ended June 30, 2009 August 31, 2009 TORONTO - Cannasat Therapeutics Inc. (TSXV: CTH), a clinical stage pharmaceutical
Cannasat Therapeutics Reports Results for the Three Months Ended March 31, 2009
Marketwire  May 29  Comment 
TORONTO -- (Marketwire) -- 05/29/09 -- Cannasat Therapeutics Inc. (TSX-V: CTH), a clinical stage pharmaceutical company developing products to treat neurological disorders such as neuropathic pain and schizophrenia, today announced its results for
Cannasat Therapeutics Announces Favourable Decision From United States Patent and Trademark Office
Marketwire  May 25  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 05/25/09 -- Cannasat Therapeutics (TSX VENTURE: CTH) ("Cannasat" or the "Company") is pleased to announce today that the United States Patent and Trademark Office ("USPTO") has issued a Notice of Allowance for a
Cannasat Therapeutics Reports Results for the Year Ended December 31, 2008
Marketwire  Apr 20  Comment 
TORONTO, ONTARIO -- (Marketwire) -- 04/20/09 -- Cannasat Therapeutics Inc. (TSX VENTURE: CTH), a clinical stage pharmaceutical company developing products to treat neurological disorders such as neuropathic pain and schizophrenia, today announced its




more ▼WIKI ANALYSIS
 The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.


 




References

Retrieved from "http://www.wikinvest.com/stock/Cannasat_Therapeutics_(CTH)"
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki